NVRO Research and Charts

NVRO - Nevro Corp (Healthcare: Medical Devices)

Projected Earnings Date: 2025-02-10 (Delayed quote data 2025-01-03)

Last 3.70	Change ⇓ -0.01 (-0.27%)	Volume 634,070
	Open 3.71	High 3.94	Low 3.68

8EMA (Daily) 3.78	40EMA (Daily) 4.25	50EMA (Daily) 4.40	STO (Daily) 21.634	MACD Hist (Daily) 0.009
8EMA (Weekly) 4.142	40EMA (Weekly) 7.82	50EMA (Weekly) 9.40	STO (Weekly) 6.588	MACD Hist (Weekly) 0.335


Company Profile
Nevro Corp is a medical device company. Its key product is the Senza spinal cord stimulation system, a neuromodulation platform for the treatment of chronic pain. Senza generates electrical impulses to relieve pain. The system is implanted by physicians and controlled by patients. It consists of leads, a trial stimulator, an implantable pulse generator, surgical tools, a clinician laptop programmer, a patient remote control, and a mobile charger. Nevro generates the majority of its revenue in the United States. It also receives nearly half of its revenue from Australia, the United Kingdom, and Germany.

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.